TY - JOUR
T1 - Why adverse outcome pathways need to be FAIR
AU - Wittwehr, Clemens
AU - Clerbaux, Laure-Alix
AU - Edwards, Stephen
AU - Angrish, Michelle
AU - Mortensen, Holly
AU - Carusi, Annamaria
AU - Gromelski, Maciej
AU - Lekka, Eftychia
AU - Virvilis, Vassilis
AU - Martens, Marvin
AU - Bonino da Silva Santos, Luiz Olavo
AU - Nymark, Penny
PY - 2024
Y1 - 2024
N2 - Adverse outcome pathways (AOPs) provide evidence for demonstrating and assessing causality between measurable toxicological mechanisms and human or environmental adverse effects. AOPs have gained increasing attention over the past decade and are believed to provide the necessary steppingstone for more effective risk assessment of chemicals and materials and moving beyond the need for animal testing. However, as with all types of data and knowledge today, AOPs need to be reusable by machines, i.e., machine-actionable, in order to reach their full impact potential. Machine-actionability is supported by the FAIR principles, which guide findability, accessibility, interoperability, and reusability of data and knowledge. Here, we describe why AOPs need to be FAIR and touch on aspects such as the improved visibility and the increased trust that FAIRification of AOPs provides.
AB - Adverse outcome pathways (AOPs) provide evidence for demonstrating and assessing causality between measurable toxicological mechanisms and human or environmental adverse effects. AOPs have gained increasing attention over the past decade and are believed to provide the necessary steppingstone for more effective risk assessment of chemicals and materials and moving beyond the need for animal testing. However, as with all types of data and knowledge today, AOPs need to be reusable by machines, i.e., machine-actionable, in order to reach their full impact potential. Machine-actionability is supported by the FAIR principles, which guide findability, accessibility, interoperability, and reusability of data and knowledge. Here, we describe why AOPs need to be FAIR and touch on aspects such as the improved visibility and the increased trust that FAIRification of AOPs provides.
KW - FAIR data
KW - adverse outcome pathways (AOPs)
KW - machine-actionability
KW - trust
KW - visibility
U2 - 10.14573/altex.2307131
DO - 10.14573/altex.2307131
M3 - Article
VL - 40
SP - 50
EP - 56
JO - ALTEX
JF - ALTEX
IS - 4
ER -